To combat the life-threatening viruses, there is an urgent need for antimicrobial materials that are suitable for surfaces of different textures. NAMI’s ABV formulation technology protects soft surfaces used in personal protective equipment (such as mask) and garments against a broad-spectrum of bacteria (Streptococcus Aureus and Escherichia Coli) and Human coronavirus OC43 (HCoV-OC43), 229E (HCoV-229E) with efficacy more than 99.9%.
As a Materials Expert, Nano and Advanced Materials Institute (NAMI) has a strong portfolio of innovative technologies to support and collaborate with the industry, offering frontier-applied research on advanced materials as well as technology transfer for commercialization success.
NAMI, incorporated in 2006, is designated by the Innovation and Technology Commission of the Hong Kong Government as a Research and Development Center for nanotechnology and advanced materials. NAMI undertakes and provides support for market-driven research in nanotechnology and advanced materials, and strives for commercialization of the technologies to benefit the industry and the society at large, as well as re-industrialization to promote the economic growth and sustainability of Hong Kong.